个人简介
萨布丽娜·格洛丽亚·朱莉娅·特斯托尼医生是米兰圣拉斐尔医院(IRCCS Ospedale San Raffaele)胃肠病与消化内镜科的胃肠病专家。
2010年,她毕业于圣拉斐尔生命与健康大学医学与外科学专业,并于2016年在同校获得消化系统疾病专业的专科资格。
她的专业经历包括:
- 2008年至2010年,她在圣拉斐尔医院国际消化内镜教学中心协助开展诊断与治疗性内镜教学工作;
- 2016年,她在圣拉斐尔医院胆胰内镜与内镜超声科担任志愿医生;
- 2016年至2020年,她是圣拉斐尔大学分子医学博士课程(临床与实验医学方向)研究员,同时在圣拉斐尔医院胆胰内镜与内镜超声科工作;
- 2021年,她以项目协作者身份在圣拉斐尔医院胃肠病与消化内镜科工作;
- 2022年,她在同一科室担任博士后研究员;
- 2023年,她成为圣拉斐尔医院胃肠病与消化内镜科的咨询医生,并与贝加莫 Zingonia 的 San Marco 医院胃肠病与内镜服务也有合作。
特斯托尼医生主要负责:
- 胆胰及胃肠疾病的诊疗
- 腹部超声检查
- 诊断性结肠镜和胃镜检查
- 治疗性结肠镜和胃镜操作(息肉切除术、黏膜切除术)
她是多个专业协会成员,包括意大利胰腺研究协会(AISP)、欧洲胃肠内镜学会(ESGE)、意大利消化内镜学会(SIED)、意大利胃肠病学会(SIGE)及欧洲胰腺俱乐部(EPC),并参与多个国家级和国际研究项目与联盟。
她发表了70余篇论文与专著章节,并发表了40余篇会议摘要,多次在学术会议上担任演讲嘉宾。
出版物
最新出版物
Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma
Cancers (Basel). 2023 Jul 21;15(14):3704. doi: 10.3390/cancers15143704.
Endoscopic Ultrasound-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: a case-control study
Endosc Ultrasound. 2022 Sep-Oct;11(5):383-392. doi: 10.4103/EUS-D-21-00200.
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs
Carcinogenesis. 2022 Sep 19;43(8):728-735. doi: 10.1093/carcin/bgac051.
B-lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma
Front Immunol. 2022 Mar 14; 13:867902. doi: 10.3389/fimmu.2022.867902.
Transoral incisionless fundoplication with Medigus ultrasonic surgical endostapler (MUSE) for the treatment of gastro-esophageal reflux disease: outcomes up to 3 years
Surg Endosc. 2022;36(7):5023-5031. doi: 10.1007/s00464-021-08860-w.
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer
Crit Rev Oncol Hematol. 2023 Jun; 186:104020. doi: 10.1016/j.critrevonc.2023.104020.
Gastric emptying study before gastric peroral endoscopic myotomy (G-POEM): can intragastric meal distribution be a predictor of success?
Gut. 2022 Jun 13: gutjnl-2022-327701.
Efficacy of Endoscopic Ultrasound-Guided Ablation with the HybridTherm Probe in Locally Advanced or Borderline Resectable Pancreatic Cancer: A Phase II Randomized Controlled Trial
Cancers 2021 Sep 8;13(18):4512. doi: 10.3390/cancers13184512.
Necrosis volume and Choi criteria predict the response to Endoscopic Ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer
Endosc Int Open. 2020 Oct;8(10): E1511-E1519.
Transoral incisionless fundoplication with EsophyX for gastro-esophageal reflux disease: clinical efficacy is maintained up to 10 years
Endosc Int Open 2019; 7(5): E647-E654. doi: 10.1055/a-0820-2297.